Log in or create a free account to read this content
Gain free access to this article, as well as selected content from this journal and more on nature.com
or
References
Cunningham KG, Manson W, Spring FS, Hutchinson SA. Cordycepin, a metabolic product isolated from cultures of Cordyceps militaris (Linn.) Link. Nature. 1950;166:949.
Osada H, Sonoda T, Tsunoda K, Isono K. A new biological role of sangivamycin; Inhibition of protein kinases. J Antibiot. 1989;42:102–6.
Brandish PE, et al. Modes of action of tunicamycin, liposidomycin B, and mureidomycin A: inhibition of phospho-N-acetylmuramyl-pentapeptide translocase from Escherichia coli. Antimicrob Agents Chemother. 1996;40:1640–4.
Takeuchi S, Hirayama K, Ueda K, Sakai H, Yonehara H. Blasticidin S, a new antibiotic. J Antibiot. 1958;11:1–5.
Huang KT, Misato T, Asuyama H. Selective toxicity of blasticidin S to Piricularia oryzae and Pellicularia sasakii. J Antibiot. 1964;17:71–74.
Suzuki S, et al. A new antibiotic, polyoxin A. J Antibiot. 1965;18:131.
Isono K, Asahi K, Suzuki S. Studies on polyoxins, antifungal antibiotics. 13. The structure of polyoxins. J Am Chem Soc. 1969;91:7490–505.
Takatsuki A, Arima K, Tamura G. Tunicamycin, a new antibiotic. I isolation and characterization of tunicamycin A. J Antibiot. 1971;24:215–23.
Takatsuki A, Tamura G. Tunicamycin, a new antibiotic. II some biological properties of the antiviral activity of tunicamycin. J Antibiot. 1971;24:224–31.
Takatsuki A, Tamura G. Tunicamycin, a new antibiotic. III reversal of the antiviral activity of tunicamycin by aminosugars and their derivatives. J Antibiot. 1971;24:232–8.
Ito T, Takatsuki A, Kawamura K, Sato K, Tamura G. Isolation and structures of components tunicamycin. Agric Biol Chem. 1980;44:695–8.
Ikeda M, Wachi M, Jung HK, Ishino F, Matsuhashi M. The Escherichia coli mraY gene encoding UDP-N-acetylmuramoyl-pentapeptide: undecaprenyl-phosphate phospho-N-acetylmuramoyl-pentapeptide transferase. J Bacteriol. 1991;173:1021–6.
He L, et al. ATM blocks tunicamycin-induced endoplasmic reticulum stress. FEBS Lett. 2009;583:903–8.
Wu J, et al. Tunicamycin specifically aggravates ER stress and overcomes chemoresistance in multidrug-resistant gastric cancer cells by inhibiting N-glycosylation. J Exp Clin Cancer Res. 2018;37:272.
Kimura K, et al. New type of liposidomycin that inhibit bacterial peptidoglycan synthesis and are produced by Streptomyces. I. Producing organism and medium components. J Antibiot. 1998;51:640–6.
Kimura K, et al. New type of liposidomycin that inhibit bacterial peptidoglycan synthesis and are produced by Streptomyces. II. Isolation and structure elucidation. J Antibiot. 1998;51:647–54.
Kimura K, et al. Selective inhibition of the bacterial peptidoglycan biosynthesis by the new types of liposidomycins. J Antibiot. 1998;51:1099–104.
Igarashi M, et al. Caprazamycin B, a novel anti-tuberculosis antibiotic, from Streptomyces sp. J Antibiot. 2003;56:580–3.
Igarashi M, et al. Caprazamycins, novel lipo-nucleoside antibiotics, from Streptomyces sp. II. Structure elucidation of caprazamycins. J Antibiot. 2005;58:327–37.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Additional information
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Osada, H. Special issue: Nucleoside antibiotics, polyoxin and beyond. J Antibiot 72, 853–854 (2019). https://doi.org/10.1038/s41429-019-0238-0
Received:
Accepted:
Published:
Issue date:
DOI: https://doi.org/10.1038/s41429-019-0238-0